Constipation affects 25 to 30% of young children2 which means approximately one in three children will struggle with this condition.
When is the best time to talk to your doctor?
PHOENIX, May 3, 2019 /PRNewswire/ -- Constipation affects 25 to 30% of young children2 which means approximately one in three children will struggle with this condition. Constipation also increases the risk of urinary tract infections. Delays in treating the issue can have damaging consequences. 25% of those children will continue to have constipation issues into their adulthood. DocuSol®Kids mini-enema (https://docusolkids.com/) was developed as an effective solution for this common health issue.
According to Johns Hopkins Children’s Center1, doctors see children with constipation daily, with a 30 percent jump in constipation-related visits between 2008 and 2009. Doctors warn that constipation in children is often treated too late, treated inadequately or goes untreated altogether and can lead to serious problems. Including hard stools that cause irritation or tearing of the lining of the rectum or anus. Such complications make it painful to have bowel movements, prompting children to avoid the bathroom altogether, thus exacerbating the overall issue.
The Johns Hopkins Children’s Center also notes that some of the following signs might indicate a good time to speak with a doctor about a child’s bathroom habits:
- Refuses to go, or hides in a private place.
- Lumpy and hard stools, small and pellet-like.
- Bloating or feeling of fullness.
- Straining with bowel movements.
- Small liquid or soft stool marks found on a child’s underwear.
Stool softener enemas are sometimes necessary for children in distress. DocuSol®Kids was designed for easy use at home. The DocuSol®Kids tube is designed to offer a soft and flexible tip. DocuSol® Kids’ mini-enemas contain a delivered dose of 100mg docusate sodium. The enemas are intended for use with children 2–12 years of age (with adult supervision). DocuSol® Kids provides fast, predictable results, typically within 2–15 minutes2.
Parents and caregivers can count on DocuSol® Kids for an easy, safe and fast acting rectal therapy. DocuSol®Kids products can be found on shelves at local retailers. Additional information is available online at: www.DocuSolKids.com.
Disclaimer: The material contained is for reference purposes only and obtained through public domain. Alliance Labs, LLC and Summit Pharmaceuticals do not assume responsibility for patient care or the accuracy of the processes or information presented. Contact a physician prior to use.
About Alliance Labs
Alliance Labs offers the highest quality incontinence products to the federal government, national pharmaceutical wholesalers, retailers and healthcare providers across the country. Alliance Labs is the distributor of both the DocuSol® and Enemeez® product lines. The staff at Alliance Labs is dedicated to researching and pursuing product lines designed to improve the lives of the patients they serve. Learn more at: www.DocuSolKids.com.
Contact:
Brittney Valentine
602-559-5210
205788@email4pr.com
1 Plugged Up: Doctors See Signs of Worsening Constipation in Adolescents, October 25, 2010; http://www.hopkinsAdolescentss.org/Plugged-Up-Doctors-See- Signs-of-Worsening-Constipation-in-Adolescents.aspx
2 Chronic constipation easy to overlook, hurts children, Published: Monday, October 15, 2012, 8:00 PM. http://www.cleveland.com/healthfit/index.ssf/2012/ 10/chronic_constipation_easy_to_o.html
3 Excerpt from Society of Gastroenterology Nurses and Associations: 2010. Primary Care: Constipation and Encopresis Treatment Strategies and Reasons to Refer
4 Federal Register/Vol. 50, No. 10/Tuesday, January 15, 1985/Proposed Rules, pgs. 2124 to 2158
Science Daily and Johns Hopkins Children’s Center / October 27, 2010. 2. Federal Register / Vol. 50, No. 10 / Tuesday, January 15, 1985 / Proposed Rules; pgs. 2124-2158.
View original content to download multimedia:http://www.prnewswire.com/news-releases/constipation-is-an-often-serious-and-untreated-condition-in-children-300843462.html
SOURCE Alliance Labs